Latest Breaking News On - Ankylosing spondylitis disease activity score - Page 1 : comparemela.com

Testing thresholds in cases of axial spondyloarthritis: Is the ASDAS appropriate for everyday clinical practice?

Testing thresholds in cases of axial spondyloarthritis: Is the ASDAS appropriate for everyday clinical practice?
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Casper webersEuropean alliance of associationsEuropean allianceAnkylosing spondylitis disease activity scoreScientific abstracts

TNF inhibitor efficacy in axial spondyloarthritis varies greatly by sex via BASDAI score

The effectiveness of TNF inhibitors for axial spondyloarthritis varies significantly between men and women based on BASDAI score, but not ASDAS, according to data published in Arthritis Research & Therapy. After 1 year of treatment, men were more likely to demonstrate effective response according to the Bath Ankylosing Spondylitis Disease Activity Score (BASDAI), while there was no

South koreaSoult ukpyolsiSeulkee leeShenaz baghaByjustin cooperSungkyunkwan university school of medicineArthritis research therapyKorean college of rheumatology biologicsArthritis researchAnkylosing spondylitis disease activity scoreSungkyunkwan university schoolKorean collegeRheumatology biologicsTargeted therapy

Neuropathic Pain Linked to Poor Sleep Quality in Patients with PsA

Among other manifestations, patients with PsA and neuropathic pain tended to have higher leptin levels, poor sleep quality, and greater levels of fatigue.

San carlosEsther toledanoSalamanca university hospitalHealth assessment questionnaireSan carlos clinical hospitalFrancesc de borja hospitalDisease activity indexPsoriatic arthritisAnkylosing spondylitis disease activity scoreHealth assessment questionnaire disability indexPsoriatic arthritis impact

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

Peuropean league against rheumatismAmerican college of rheumatologyHospital anxietyDepression scaleAmerican collegeDisease activity scoreClinical disease activity indexSimplified disease activityAnkylosing spondylitis disease activity score

Depression May Impact bDMARD Treatment Response and Discontinuation in Patients With Psoriatic Arthritis

Depression may impact psoriatic arthritis (PsA) treatment response and lead to higher rates of biologic disease-modifying antirheumatic drug (bDMARD) Depression may impact PsA treatment response and lead to higher rates of bDMARD discontinuation, which may affect disease management and progression.

American college of rheumatologyPeuropean league against rheumatismHospital anxietyDepression scaleAmerican collegeDisease activity scoreClinical disease activity indexSimplified disease activityAnkylosing spondylitis disease activity score